摘要
保留肾单位手术(NSS)是T1和部分T2期肾细胞(RCC)癌患者治疗的标准术式,但通常不推荐用于T3期肾细胞癌。由于术前影像学诊断肾细胞癌TNM分期的敏感性和特异性有限,所以部分cT1/2术后升期为pT3a期肾细胞癌的患者也接受了NSS治疗。NSS与根治性肾切除术治疗术后升期为pT3a期肾细胞癌患者的疗效仍存在较大争议。本文主要总结了T3a期肾细胞癌患者术前影像学诊断标准,术后病理分期升级为pT3a的危险因素,并比较了NSS与根治性肾切除术治疗术后升期为pT3a期肾细胞癌患者的疗效及预后差异。
Nephron-sparing surgery(NSS)is the standard treatment method for T1 and some T2 stage renal cell carcinoma(RCC),but it is not recommended for T3 stage RCC.Due to the limited sensitivity and specificity of preoperative imaging,some cT1/2 upstaging to pT3a RCC patients also receive NSS.The efficacy of NSS versus radical nephrectomy for upstaging to T3a RCC remains highly controversial.This article summarizes the preoperative imaging diagnostic criteria of T3a RCC and risk factors of upstaging to pT3a,and compares the efficacy and prognosis between NSS and radical nephrectomy for upstaging to pT3a RCC.
作者
王柯若
刘雅茹
李刚
WANG Keruo;LIU Yaru;LI Gang(Tianjin Institute of Urology,Department of Urology,The Second Hospital of Tianjin Medical Univer-sity,Tianjin 300211;Emergency Department,The Second Hospital of Tianjin Medical University,Tianjin 300211,China)
出处
《现代泌尿外科杂志》
CAS
2023年第8期725-728,共4页
Journal of Modern Urology
关键词
保留肾单位手术
肾细胞癌
危险因素
病理分期
影像学
根治性肾切除术
nephron-sparing surgery
renal cell carcinoma
risk factors
pathological staging
imaging
radical nephrectomy
